Literature DB >> 31760429

Impact of Race on the Association of Mineral Metabolism With Heart Failure: the Multi-Ethnic Study of Atherosclerosis.

Cassianne Robinson-Cohen1, Michael Shlipak2, Mark Sarnak3, Ronit Katz4, Carmen Peralta2,5, Bessie Young4, Andrew N Hoofnagle6, Moyses Szklo7, Joachim H Ix8, Bruce M Psaty9, Ian H de Boer4, Bryan Kestenbaum4, Nisha Bansal4.   

Abstract

BACKGROUND: Alterations in mineral metabolism, such as high phosphorus, high parathyroid hormone (PTH), and high fibroblast growth factor-23 (FGF-23) have been identified as potential risk factors for heart failure (HF). Important differences in the prevalence of mineral metabolism abnormalities and in the risk of HF have been reported across race and/or ethnic groups. In this study, we evaluated whether the associations of mineral metabolism markers with HF differed by race and/or ethnicity.
METHODS: We included participants free of cardiovascular disease from the Multi-Ethnic Study of Atherosclerosis to quantify rates of HF overall and across race and/or ethnic groups. Using Cox models, we tested associations of baseline higher phosphorus (>4 mg/dL), PTH greater than 65 pg/mL, and FGF-23 greater than 46.5 pg/mL with incident HF, and for interactions by race and/or ethnicity, adjusting for sociodemographic and cardiovascular risk factors.
RESULTS: Among the 6413 participants, median follow-up time was 14.9 years. The incidence rate for HF was highest for African Americans and lowest for Chinese (4.71 and 2.42 per 1000 person-years, respectively). The prevalence of elevated PTH (18.8% vs 7.4%) but not FGF-23 (23.1% vs 28.8%) was higher in African Americans vs Whites. In multivariable models, the associations of elevated PTH (hazard ratio [HR] 1.50, 95% CI: 1.13-1.99) and FGF-23 (HR 1.37, 95% CI: 1.07-1.75) with incident HF were statistically significant. However, the interactions by race and/or ethnicity were not statistically significant.
CONCLUSIONS: In a multiethnic population, higher PTH and FGF-23 were associated with risk of HF in African American and Hispanic individuals. There is no evidence that race and/or ethnicity modifies the association of altered mineral metabolism with risk of HF. © Endocrine Society 2019. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  fibroblast growth factor-23; heart failure; mineral metabolism; parathyroid hormone; phosphorus

Year:  2020        PMID: 31760429      PMCID: PMC7064305          DOI: 10.1210/clinem/dgz218

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  28 in total

Review 1.  Estimating causal effects from large data sets using propensity scores.

Authors:  D B Rubin
Journal:  Ann Intern Med       Date:  1997-10-15       Impact factor: 25.391

2.  Racial differences in markers of mineral metabolism in advanced chronic kidney disease.

Authors:  Anna Jovanovich; Michel Chonchol; Alfred K Cheung; James S Kaufman; Tom Greene; William L Roberts; Gerard Smits; Jessica Kendrick
Journal:  Clin J Am Soc Nephrol       Date:  2012-03-01       Impact factor: 8.237

3.  Parathyroid hormone and vitamin D--markers for cardiovascular and all cause mortality in heart failure.

Authors:  Louise Lind Schierbeck; Torben Slott Jensen; Ulrich Bang; Gorm Jensen; Lars Køber; Jens-Erik Beck Jensen
Journal:  Eur J Heart Fail       Date:  2011-03-17       Impact factor: 15.534

4.  Race is a major determinant of secondary hyperparathyroidism in uremic patients.

Authors:  Ajay Gupta; Lee R Kallenbach; Gerard Zasuwa; George W Divine
Journal:  J Am Soc Nephrol       Date:  2000-02       Impact factor: 10.121

5.  Estimating glomerular filtration rate from serum creatinine and cystatin C.

Authors:  Lesley A Inker; Christopher H Schmid; Hocine Tighiouart; John H Eckfeldt; Harold I Feldman; Tom Greene; John W Kusek; Jane Manzi; Frederick Van Lente; Yaping Lucy Zhang; Josef Coresh; Andrew S Levey
Journal:  N Engl J Med       Date:  2012-07-05       Impact factor: 91.245

6.  Multiple imputation using chained equations: Issues and guidance for practice.

Authors:  Ian R White; Patrick Royston; Angela M Wood
Journal:  Stat Med       Date:  2010-11-30       Impact factor: 2.373

7.  Race, Mineral Homeostasis and Mortality in Patients with End-Stage Renal Disease on Dialysis.

Authors:  Julia J Scialla; Rulan S Parekh; Joseph A Eustace; Brad C Astor; Laura Plantinga; Bernard G Jaar; Tariq Shafi; Josef Coresh; Neil R Powe; Michal L Melamed
Journal:  Am J Nephrol       Date:  2015-08-20       Impact factor: 3.754

8.  Parathyroid hormone and arterial dysfunction in the multi-ethnic study of atherosclerosis.

Authors:  Cortney Bosworth; Michael C Sachs; Daniel Duprez; Andrew N Hoofnagle; Joachim H Ix; David R Jacobs; Carmen A Peralta; David S Siscovick; Bryan Kestenbaum; Ian H de Boer
Journal:  Clin Endocrinol (Oxf)       Date:  2013-05-20       Impact factor: 3.478

9.  Multi-Ethnic Study of Atherosclerosis: objectives and design.

Authors:  Diane E Bild; David A Bluemke; Gregory L Burke; Robert Detrano; Ana V Diez Roux; Aaron R Folsom; Philip Greenland; David R Jacob; Richard Kronmal; Kiang Liu; Jennifer Clark Nelson; Daniel O'Leary; Mohammed F Saad; Steven Shea; Moyses Szklo; Russell P Tracy
Journal:  Am J Epidemiol       Date:  2002-11-01       Impact factor: 4.897

10.  The severity of secondary hyperparathyroidism in chronic renal insufficiency is GFR-dependent, race-dependent, and associated with cardiovascular disease.

Authors:  Ian H De Boer; Irina Gorodetskaya; Belinda Young; Chi-Yuan Hsu; Glenn M Chertow
Journal:  J Am Soc Nephrol       Date:  2002-11       Impact factor: 10.121

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.